• Title Validation of rapid, molecular testing for COVID-19 and integration with TB diagnostics
  • Granting Agency CIHR (Canadian Institutes of Health Sciences) & IDRC (International Development Research Centre)
  • Period 1 Aug. 2020 – 31 March 2023
  • Amount $421,479 CAD

The objective of this project was to respond to the double burden of disease of COVID-19 and TB by investigating the diagnostic accuracy and feasibility of integrated COVID-19 and TB testing on the GeneXpert platform. It also included complementary work to strengthen diagnostic tools for TB and COVID-19.

Publications

MacLean, Emily Lai-Ho; Villa-Castillo, Luz; Espinoza-Lopez, Patricia; Caceres, Tatiana; Sulis, Giorgia; Kohli, Mikashmi; Pai, Madhukar; Ugarte-Gil, César

Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study (Journal Article)

In: The Lancet Microbe, vol. 4, iss. 6, pp. e452 - e460, 2023.

(Links)

Zimmer, Alexandra J; Ugarte-Gil, César; Pathri, Rahul; Dewan, Puneet; Jaganath, Devan; Cattamanchi, Adithya; Pai, Madhukar; Lapierre, Simon Grandjean

Making cough count in tuberculosis care (Journal Article)

In: Communications Medicine, vol. 2, no. 1, pp. 1–8, 2022.

(Links)

MacLean, Emily L; Villa-Castillo, Luz; Ruhwald, Morten; Ugarte-Gil, César; Pai, Madhukar

Integrated testing for TB and COVID-19 (Journal Article)

In: Med, vol. 3, no. 3, pp. 162-166, 2022.

(Links)